The Clinical Picture of Patients Suffering from Hypophosphatasia—A Rare Metabolic Disease of Many Faces
Hypophosphatasia (HPP) is a rare, and usually diagnosed with delay, genetic disease caused by a mutation in the alkaline phosphatase liver/bone/kidney type (ALPL) gene. Low activity of the alkaline phosphatase (ALP) impairs the hydroxyapatite formation, reducing skeletal mineralization. The aim of t...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/4/865 |
_version_ | 1797436060571009024 |
---|---|
author | Izabela Michałus Aneta Gawlik Katarzyna Wieczorek-Szukała Andrzej Lewiński |
author_facet | Izabela Michałus Aneta Gawlik Katarzyna Wieczorek-Szukała Andrzej Lewiński |
author_sort | Izabela Michałus |
collection | DOAJ |
description | Hypophosphatasia (HPP) is a rare, and usually diagnosed with delay, genetic disease caused by a mutation in the alkaline phosphatase liver/bone/kidney type (ALPL) gene. Low activity of the alkaline phosphatase (ALP) impairs the hydroxyapatite formation, reducing skeletal mineralization. The aim of the study was to present patients diagnosed with HPP. The data from the history and medical records of patients were analyzed. In the study group, one patient was diagnosed with perinatal type of HPP, three were diagnosed with infant variant, eight were diagnosed with children variant, two were diagnosed with odontohypophosphatasia, and two were diagnosed with the adult type of the disease. The most frequently presented symptoms included premature loss of teeth in 11/16 (68.75%) patients, bone deformities in 10/16 (62.5%) patients, chronic bone pain in 9/16 (56.25%) patients, and fractures in 8/16 (50%) patients. Reduction in bone mineral density in at least one examined projection has been found in 11/14 patients. Conclusions: The correct diagnosis of HPP is difficult due to the variety of types and clinical symptoms, as well as the very rare occurrence of this disease. Both lower and upper reference values of the determined biochemical parameters may be important in HPP diagnostics. |
first_indexed | 2024-03-09T10:57:14Z |
format | Article |
id | doaj.art-5d5f73a69f7842bb982e98a989124452 |
institution | Directory Open Access Journal |
issn | 2075-4418 |
language | English |
last_indexed | 2024-03-09T10:57:14Z |
publishDate | 2022-03-01 |
publisher | MDPI AG |
record_format | Article |
series | Diagnostics |
spelling | doaj.art-5d5f73a69f7842bb982e98a9891244522023-12-01T01:31:59ZengMDPI AGDiagnostics2075-44182022-03-0112486510.3390/diagnostics12040865The Clinical Picture of Patients Suffering from Hypophosphatasia—A Rare Metabolic Disease of Many FacesIzabela Michałus0Aneta Gawlik1Katarzyna Wieczorek-Szukała2Andrzej Lewiński3Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital-Research Institute, 93-338 Lodz, PolandDepartment of Pediatrics and Pediatric Endocrinology, Faculty of Medical Sciences, Medical University of Silesia, 40-759 Katowice, PolandDepartment of Endocrinology and Metabolic Diseases, Medical University of Lodz, 90-419 Lodz, PolandDepartment of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital-Research Institute, 93-338 Lodz, PolandHypophosphatasia (HPP) is a rare, and usually diagnosed with delay, genetic disease caused by a mutation in the alkaline phosphatase liver/bone/kidney type (ALPL) gene. Low activity of the alkaline phosphatase (ALP) impairs the hydroxyapatite formation, reducing skeletal mineralization. The aim of the study was to present patients diagnosed with HPP. The data from the history and medical records of patients were analyzed. In the study group, one patient was diagnosed with perinatal type of HPP, three were diagnosed with infant variant, eight were diagnosed with children variant, two were diagnosed with odontohypophosphatasia, and two were diagnosed with the adult type of the disease. The most frequently presented symptoms included premature loss of teeth in 11/16 (68.75%) patients, bone deformities in 10/16 (62.5%) patients, chronic bone pain in 9/16 (56.25%) patients, and fractures in 8/16 (50%) patients. Reduction in bone mineral density in at least one examined projection has been found in 11/14 patients. Conclusions: The correct diagnosis of HPP is difficult due to the variety of types and clinical symptoms, as well as the very rare occurrence of this disease. Both lower and upper reference values of the determined biochemical parameters may be important in HPP diagnostics.https://www.mdpi.com/2075-4418/12/4/865hypophosphatasiarare diseasebone metabolic disease |
spellingShingle | Izabela Michałus Aneta Gawlik Katarzyna Wieczorek-Szukała Andrzej Lewiński The Clinical Picture of Patients Suffering from Hypophosphatasia—A Rare Metabolic Disease of Many Faces Diagnostics hypophosphatasia rare disease bone metabolic disease |
title | The Clinical Picture of Patients Suffering from Hypophosphatasia—A Rare Metabolic Disease of Many Faces |
title_full | The Clinical Picture of Patients Suffering from Hypophosphatasia—A Rare Metabolic Disease of Many Faces |
title_fullStr | The Clinical Picture of Patients Suffering from Hypophosphatasia—A Rare Metabolic Disease of Many Faces |
title_full_unstemmed | The Clinical Picture of Patients Suffering from Hypophosphatasia—A Rare Metabolic Disease of Many Faces |
title_short | The Clinical Picture of Patients Suffering from Hypophosphatasia—A Rare Metabolic Disease of Many Faces |
title_sort | clinical picture of patients suffering from hypophosphatasia a rare metabolic disease of many faces |
topic | hypophosphatasia rare disease bone metabolic disease |
url | https://www.mdpi.com/2075-4418/12/4/865 |
work_keys_str_mv | AT izabelamichałus theclinicalpictureofpatientssufferingfromhypophosphatasiaararemetabolicdiseaseofmanyfaces AT anetagawlik theclinicalpictureofpatientssufferingfromhypophosphatasiaararemetabolicdiseaseofmanyfaces AT katarzynawieczorekszukała theclinicalpictureofpatientssufferingfromhypophosphatasiaararemetabolicdiseaseofmanyfaces AT andrzejlewinski theclinicalpictureofpatientssufferingfromhypophosphatasiaararemetabolicdiseaseofmanyfaces AT izabelamichałus clinicalpictureofpatientssufferingfromhypophosphatasiaararemetabolicdiseaseofmanyfaces AT anetagawlik clinicalpictureofpatientssufferingfromhypophosphatasiaararemetabolicdiseaseofmanyfaces AT katarzynawieczorekszukała clinicalpictureofpatientssufferingfromhypophosphatasiaararemetabolicdiseaseofmanyfaces AT andrzejlewinski clinicalpictureofpatientssufferingfromhypophosphatasiaararemetabolicdiseaseofmanyfaces |